Owner Novartis AG

Inventors Buerger, Hans, Michael; Schmitz, Beat; Abel, Stephan; Loiseleur, Olivier; Meisenbach, Mark; Sedelmeier, Gottfried; Kaufmann, Daniel

Agent Davies Collison Cave

Pub. Number AU-B-2003244444

PCT Number PCT/EP03/01188

PCT Pub. Number WO2003/066613

Priority 0202873.6 07.02.02 GB

Filing date 6 February 2003

Wipo publication date 2 September 2003

Acceptance publication date 9 August 2007

C07D 295/12 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 295/155 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings